Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardinal Plans Generic Cardiolite, Other Moves To Expand Generic Presence

Executive Summary

Cardinal Health expects to market its own generic version of Bristol-Myers Squibb's cardiac imaging agent Cardiolite (technetium Tc99m sestamibi) as part of a plan to expand its role in the generic sector

You may also be interested in...



Generic Industry Faces Downturn, Sandoz Says; MMA Changes Hurt

The generic industry is facing a "downturn" in the market for products with low barriers to entry, Sandoz CEO Andreas Rummelt said Jan. 20

Generic Industry Faces Downturn, Sandoz Says; MMA Changes Hurt

The generic industry is facing a "downturn" in the market for products with low barriers to entry, Sandoz CEO Andreas Rummelt said Jan. 20

Teva Anticipates “Major Consolidation” In Generic Industry In 2005

Teva is preparing for another round of consolidation within the generic industry during 2005, North America CEO George Barrett said Jan. 13 at the J.P. Morgan health care conference in San Francisco

Related Content

Topics

UsernamePublicRestriction

Register

PS045241

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel